It has been a challenging 5-year period since 4DMedical Ltd (ASX: 4DX) IPO’d in 2020.

At one point, the company’s share price was down 90% from its October 2020 all-time high of $2.60, but things finally seem to be turning around. In fact, one could argue that 2025 is turning out to be a breakout year for the medical technology company.

The company’s share price is now up a staggering 680% since July and is currently trading at $1.89. Moves like that usually trigger two reactions: “I missed the boat” or “This must be a bubble”, so what exactly has contributed to this remarkable recovery?

Consistent contract wins

The first clear signal for investors was the steady drumbeat of new deal announcements throughout the year. 4D Medical has been consistently locking down renewals and new agreements with some notable clients.

In July, they secured a 3-year contract renewal with the University of Michigan, and the company has recently expanded its agreement with Stanford University to include the new CT:VQ technology, whilst also entering into local deals with Royal Melbourne Hospital.

Recently, the company announced that Phillips would add CT:VQ to its North American product catalogue, backed by a minimum $15m contractual order commitment over 2 years.

While the contract sizes vary, the consistency of these wins with such prestigious institutions showed the market that the technology was gaining genuine traction.

The FDA green light

The company cleared a major hurdle on September 1, 2025, when it received FDA clearance for CT:VQ. CT:VQ is a software-as-a-service (SaaS) product that enables doctors to scan for pulmonary embolisms (blood clots) using a standard CT scan, without the need for contrast dye or radioactive tracers.

The FDA clearance opens up an addressable market of US$1.1 billion in the US alone, and it solves a logistical nightmare for hospitals by removing the need for nuclear medicine teams, meaning 4D Medical isn’t just selling software; it’s selling efficiency.

Investment from Pro Medicus

In July, Pro Medicus Ltd (ASX: PME), the $26 billion ASX medical imaging giant, invested $10 million into 4D Medical.

The investment was structured as a hybrid debt/equity facility. This means that while it provides 4D Medical with non-dilutive cash to grow, it also gives Pro Medicus “upside alignment.” If 4D Medical’s share price performs strongly over the two-year term, Pro Medicus stands to gain more.

Pro Medicus is the poster child of what success looks like for a medical imaging company listed on the ASX and selling its products in the US. If 4D Medical can follow in those footsteps, then there is plenty more upside to come.

Foolish bottom line

4D Medical’s stunning turnaround is the product of real traction. With consistent contract wins, FDA clearance unlocking a billion-dollar US market, and strategic backing from Pro Medicus, the company is adding credibility, capital, and a commercial pathway to success.

The risks aren’t gone, but for the first time since its IPO, 4D Medical looks less like a speculative bet and more like a business that’s beginning to deliver.

The post Up 680% since July, here’s why 2025 was a breakout year for this hot ASX stock appeared first on The Motley Fool Australia.

More reading

• Guess which ASX tech stock could rise 40% in 2026
• 5 things to watch on the ASX 200 on Thursday
• Why 4DMedical, Dateline, Predictive Discovery, and Wildcat shares are racing higher
• Why this exciting ASX tech stock is rocketing 18% today

Motley Fool contributor Kevin Gandiya has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Monash IVF Group Ltd (ASX: MVF) share price is trading in the red at Friday lunchtime. At the time of writing, the shares are 1.73% lower for the day at 85 cents a piece.

The ASX All Ords stock’s share price stormed 44% higher two weeks ago on the 24th November after the company received and rejected “an opportunistic, unsolicited, conditional and non-binding indicative proposal” from a consortium comprising Genesis Capital and Washington H. Soul Pattinson and Co Ltd (ASX: SOL). 

For context, the All Ordinaries Index (ASX: XAO) is 0.12% higher today. Over the past two weeks, the index has climbed 1.3%.

For the year-to-date, the specialist assisted reproductive services provider’s shares are still 32.28% lower, thanks to several sharp sell-offs earlier in the year.

And now Macquarie Group Ltd (ASX: MQG) analysts have weighed in on the shares.

Here’s what the broker had to say.

Limited upside ahead for this ASX All Ords stock

In a note to investors, the team at Macquarie downgraded Monash IVF’s shares to neutral from a previous outperform rating. The target price remains unchanged at 94 cents. 

At the time of writing, this implies a potential 10.6% upside for investors over the next 12 months.

“We move our recommendation to Neutral, from Outperform. While we continue to expect medium-term upside on an improving macro environment, increased genetic testing, underlying structural demands, demographic and social changes, we think the share price is approaching fair value,” the broker said in its note.

Macquarie said that increased competition, recent operational incidents, and regulatory costs weigh on Monash IVF’s outlook. The broker sees the current share price as close to fair value. 

Despite the lower offer relative to historical benchmarks, the outlook for IVF has changed since CY22. Incidents have potentially weighed on customer acquisition and triggered greater regulatory scrutiny, likely increasing compliance costs as additional safeguards are implemented. Aggressive competition from unlisted peers, especially in VIC, is adding pressure. As such, we believe MVF’s share price appears close to fair value.

What did Macquarie say about the bid rejection?

Two weeks ago, Monash IVF rejected an 80 cent per share cash offer from a private equity consortium comprising Genesis Capital and Soul Patts. The two companies currently hold 19.6% of ASX All Ords company’s shares.

Macquarie explained that the offer implied a company valuation of 7.7 times its FY25 EBITDA. This is substantially less than comparable transactions in the sector.

“Despite a 31% premium to the pre-bid share price, the board’s decision reflects their view that the bid materially undervalues MVF’s strategic position and longer-term prospects,” Macquarie said in its note to investors.

For context, Monash IVF’s rival Virtus Health was acquired by BGH Capital in 2022 after a takeover battle. The sale represented 11.9 times the company’s EBIDTA, Macquarie explained in its note.

“However, it’s important to note that market conditions have since shifted, with FY21 benefiting from COVID-driven demand. Further, on a FY26E basis, MVF’s offer multiple increases to 8.6x (MRE EBITDA forecasts), as earnings are expected to reduce,” Macquarie said.

The post After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded appeared first on The Motley Fool Australia.

More reading

• Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today
• Analysts rate CBA and these popular ASX shares as sells
• Why Gentrack, Monash IVF, Pro Medicus, and Qube shares are racing higher today
• This Aussie fertility company has rejected a takeover bid from private equity
• Macquarie tips 54% upside for this beaten down ASX All Ords healthcare stock

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Macquarie Group and Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

In afternoon trade on Friday, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down slightly to 8,615.2 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are tumbling:

Collins Foods Ltd (ASX: CKF)

The Collins Foods share price is down over 3% to $10.22. This has been driven by the quick service restaurant operator’s shares going ex-dividend this morning. Earlier this week, the company released its half year results and declared a fully franked interim dividend of 13 cents per share. This dividend will be paid to eligible shareholders early next month on 5 January

Monash IVF Group Ltd (ASX: MVF)

The Monash IVF share price is down 2.5% to 84.2 cents. This may have been driven by a broker note out of Macquarie this morning. According to the note, the broker has downgraded the fertility treatment company’s shares to a neutral rating with a 94 cents price target. It said: “We move our recommendation to Neutral, from Outperform. While we continue to expect medium-term upside on an improving macro environment, increased genetic testing, underlying structural demands, demographic and social changes, we think the share price is approaching fair value. Prior research.”

Premier Investments Ltd (ASX: PMV)

The Premier Investments share price is down 13% to $15.72. Investors have been selling this retailer’s shares following the release of a trading update at its annual general meeting. The Peter Alexander and Smiggle owner revealed that Premier Retail first half underlying earnings before interest and tax (EBIT) is expected to be around $120 million. This is down 7.3% on the prior corresponding period.

Step One Clothing Ltd (ASX: STP)

The Step One share price is down almost 12% to 26.5 cents. This online underwear seller’s shares have been sold off this week after it announced dismal sales results for the first half of FY 2026. Step One advised that it expects half year revenue to be in the range of $30 million and $33 million. This represents a decline of between 31% to 37% on the prior corresponding period. Things will be even worse for its EBITDA, which is expected to be a loss of between $9 million and $11 million. This is down from a profit of $11.3 million a year ago and includes a $10 million obsolescence provision against legacy stock that it has been unable to shift.

The post Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today appeared first on The Motley Fool Australia.

More reading

• Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today
• Down 80% in 2025: Is it time to buy this beaten down ASX stock?
• Why are Premier Investments shares crashing 12% today?
• Why brokers are bullish on this rapidly-growing ASX 200 share
• 3 ASX blue-chip shares I’d buy with $3,000 right now

Motley Fool contributor James Mickleboro has positions in Collins Foods. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Collins Foods and Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The NIB Holdings Ltd (ASX: NHF) share price is down 2.47% to $6.71 on Friday.

A scathing new report shows Australians are paying more for private health insurance policies but receiving fewer benefits.

The key benefits of private health insurance include help with costs, the ability to choose your doctor, shorter waiting periods for elective surgery, and a tax break for higher income earners, as having insurance means they don’t have to pay the Medicare surcharge.

The Australian Medical Association (AMA) released its 2025 Private Health Insurance Report Card today.

The report shows consumers are feeling increasingly dissatisfied with the value for money they’re getting while insurers post big profits.

For FY25, NIB reported higher revenue, lower underlying group profit, and higher net profit after tax (NPAT).

Revenue was $3.6 billion in FY25, up from $3.3 billion in FY24. Group underlying operating profit was $239.2 million, down from $257.5 million in FY24, and NPAT was $198.6 million, up 9.4% from $181.6 million in FY24.

What did the AMA say about private health insurance?

AMA President Dr Danielle McMullen said the report “reveals a system increasingly failing to deliver value for money”.

Dr McMullen said:

Premiums have risen sharply, outpacing inflation, wage growth, and Medicare indexation — while coverage has narrowed.

Sixty-eight per cent of hospital policies now contain exclusions, meaning many Australians are paying more, but are covered for less.

The report found that Australian consumers were dropping gold level policies in favour of cheaper silver and bronze packages.

Since March 2020, the number of gold health insurance policies has fallen by 360,000 while the overall number of policies has risen 640,000.

Dr McMullen commented:

The tiered product system introduced in 2020 — basic, bronze, silver, and gold — was designed to simplify choices but has instead created confusion and contributed to underinsurance.

Gold-tier policies, which provide the most comprehensive coverage, are particularly susceptible to phoenixing — a term used when insurers close an existing policy and replace it with a nearly identical one at a higher price — a practice that has become increasingly common.

Key dates for NIB shares investors in 2026

Looking ahead to 2026, here are the important dates for NIB shares investors to note.

NIB will announce its FY26 half-year results and interim dividend on 23 February.

The ex-dividend date for the interim NIB dividend will be 5 March.

If you’d like NIB to use your dividends to reinvest in more shares, you’ll need to enrol in the dividend reinvestment plan (DRP) by 9 March.

NIB shareholders will receive their dividends on 8 April.

The private health insurer will announce its FY26 full-year results and final dividend on 24 August.

The ex-dividend date for the final NIB dividend will be 3 September.

The DRP deadline will be 7 September.

NIB will pay its shareholders on 7 October.

The insurer will hold its annual general meeting on 11 November.

The post Own NIB shares? Here are the key dates for 2026 appeared first on The Motley Fool Australia.

More reading

• Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today
• 4 ASX 200 stocks smashing the benchmark this week
• Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today
• Down 8%, this passive income stock offers a 4.6% dividend yield!
• Macquarie tips 50% upside for Wisetech Global shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

As we enter the final hours of trading on Friday, the S&P/ASX 200 Index (ASX: XJO) is up a slender 0.1% for the week, with these four ASX 200 stocks doing a lot of the heavy lifting.

We have a diversified mix of companies on our top performers list this week.

One is a major bank, another provides building materials, the third is a coal miner, and the fourth is a fast-growing copper and gold producer.

Here’s what’s been happening this week.

ASX 200 stocks racing higher this week

The first outperforming company this week is Judo Capital Holdings Limited (ASX: JDO).

Shares in the ASX 200 bank stock closed last Friday trading for $1.60. At the time of writing, shares are changing hands for $1.71 each. This sees the Judo share price up 7% for the week.

With no fresh price-sensitive news out from the bank, investors may believe the stock could benefit amid increasing expectations that the RBA may raise interest rates in early 2026. High rates should help improve the bank’s net interest margin (NIM).

The second ASX 200 stock smashing the benchmark’s returns this week is Fletcher Building Ltd (ASX: FBU).

Shares in the New Zealand-based building and materials company closed last week at $2.93 and are currently trading at $3.14 apiece. This puts the Fletcher Building share price up 7.2% for the week.

This morning, the company announced additional steps it is taking to simplify its funding structure. Those steps include repaying all outstanding US Private Placement notes as well as securing new debt facilities.

“These steps represent another milestone in strengthening our financial foundations,” Fletcher Building CEO Andrew Reding said.

“Simplifying our funding structure and extending key facilities gives us greater flexibility, lowers our ongoing cost of capital, and supports the disciplined execution of our strategic reset,” Reding added.

Moving on to the third ASX 200 stock racing ahead of the benchmark this week, we find Whitehaven Coal Ltd (ASX: WHC).

Shares in the Aussie coal miner closed last Friday trading for $6.93. In afternoon trade today, shares are changing hands for $7.65 each. This sees the Whitehaven share price up 10.5% over the week.

There are no new price-sensitive announcements out from Whitehaven this week. But investors may be buying the ASX coal stock amid the company’s ongoing share buyback program and with an eye on potential rising coal prices as we enter the northern winter months.

Leading the charge

Edging out Whitehaven to lead the charge higher this week is Greatland Resources Ltd (ASX: GGP).

Shares in the Australian gold and copper producer closed last week trading at $7.55 and are currently trading at $8.40 each. That sees this ASX 200 stock up 11% for the week.

The company owns a number of quality mines in Western Australia, where it is also developing its Havieron gold and copper project.

The miner discovered Havieron in 2018 and retook 100% ownership of the project 12 months ago.

Greatland Resources shares closed up 10.2% on Monday after the company released the feasibility study for the project.

Commenting on the study, Greatland managing director Shaun Day said:

Today, we are delighted to deliver our Feasibility Study which confirms Havieron’s world-class quality and sets the pathway for its development into a long-life, low cost, leading Australian gold-copper mine that will integrate efficiently with the existing infrastructure at Telfer.

The results of the study are robust, generating an IRR [internal rate of return] of 22.5% at a long term $4,500 per ounce gold price. At a long term price equal to the current spot gold price, this rises to 31.5% IRR.

The post 4 ASX 200 stocks smashing the benchmark this week appeared first on The Motley Fool Australia.

More reading

• Fletcher Building updates funding: repays USPP, extends bank facilities
• Here are the top 10 ASX 200 shares today
• ASX bank stocks: Buy, sell, or hold?
• This ASX 200 stock could plummet 50% next year
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is on course to finish the week with a small gain. In afternoon trade, the benchmark index is up slightly to 8,620.3 points.

Four ASX shares that are rising more than most today are listed below. Here’s why they are climbing:

Bendigo and Adelaide Bank Ltd (ASX: BEN)

The Bendigo and Adelaide Bank share price is up 2% to $10.35. Investors have been buying the regional bank’s shares after analysts responded positively to its plan to acquire RACQ Bank’s retail lending assets and deposits. The purchase price will be based on the book value of the transferring book at completion, which comprised $2.7 billion of retail loans and $2.5 billion of retail deposits at the end of June. In response, Ord Minnett upgraded its shares to an accumulate rating with an $11.00 price target.

Nextdc Ltd (ASX: NXT)

The Nextdc share price is up 4% to $13.98. This follows news that the data centre operator has agreed a memorandum of understanding (MoU) with ChatGPT’s owner OpenAI. The MOU will focus on developing a sovereign AI infrastructure partnership under the OpenAI for Australia program. This will see OpenAI and NextDC collaborate on the planning, development, and operation of a next generation hyperscale AI campus and large-scale GPU supercluster at NextDC’s S7 site in Eastern Creek, Sydney. This will reportedly be the largest data centre in the southern hemisphere.

Nuix Ltd (ASX: NXL)

The Nuix share price is up 3% to $1.87. This investigative analysis software provider’s shares have been pushing higher this week after it announced an acquisition. Nuix advised that it has agreed to acquire graph-powered AI decision platform Linkurious for up to 20 million euros (~A$35.4 million). Nuix’s interim CEO, John Ruthven, said: “The acquisition of Linkurious is an exciting accelerator for our strategic vision to enable our customers with insights from complex data at unparalleled speed and scale. This injection of graph-native expertise, proven link analysis technology and quality customers will allow us to bring immediate value to our customers.”

Vulcan Energy Resources Ltd (ASX: VUL)

The Vulcan Energy share price is up 10% to $4.50. This lithium developer’s shares are rebounding after a significant decline on Thursday. That decline was driven by the company’s capital raising. Vulcan Energy’s institutional offer raised 398 million euros (A$710 million) at $4.00 per new share. This represented a 34.7% discount to its share price at the time. Vulcan’s managing director and CEO, Cris Moreno, said: “We would like to thank our existing shareholders for their continued support and welcome our new shareholders onto the register, including strategic investors. The Placement will enable Vulcan to transition from development phase into execution phase with project execution of Project Lionheart due to commence in the coming days.”

The post Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today appeared first on The Motley Fool Australia.

More reading

• Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today
• This bank’s shares could deliver double-digit returns analysts say
• NextDC shares jump 11% on major OpenAI deal
• 5 things to watch on the ASX 200 on Friday
• 3 ASX blue-chip shares I’d buy with $3,000 right now

Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo And Adelaide Bank. The Motley Fool Australia has recommended Nuix. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Many, if not most, of the most popular passive income stocks on the ASX have reset their record highs over the past 12 months. That includes Commonwealth Bank of Australia (ASX: CBA), Wesfarmers Ltd (ASX: WES) and Coles Group Ltd (ASX: COL). Believe it or not, there’s a popular income stock that last hit a new all-time high more than five years ago.

That passive income stock is none other than toll-road operator Transurban Group (ASX: TCL). Yes, Transurban shares last hit an all-time high back in February of 2020, briefly crossing $16 a share for the first (and so far only) time in its history before topping out at $16.30.

Then, the COVID-19 pandemic hit, and Transurban was down to under $11 a share two months later.

The company has recovered, of course, but never reached those heights since. Today, at $14.97 a share at the time of writing, Transurban remains down more than 8% from that all-time high from almost six years ago.

Despite this share price stagnation, the Transurban dividend has never been higher.

The company did have to slash its shareholder payouts for a few years, thanks to the effects of the pandemic (collecting tolls was a tough business back then with all of the lockdowns and such).

Over 2019, this passive income stock paid out a total of 59 cents per share in dividends. But that fell to just 47 cents in 2020 and 3.65 cents in 2021.

However, 2022 saw the company’s dividends begin to recover. That year had Transurban fork out 41 cents per share, which rose to 58 cents in 2023. 2024 saw investors get another pay rise, which finally broke the 2019 record with 62 cents per share doled out over that year.

This passive income stock is set to pay a 4.6% yield

This year, that record was broken again. Transurban paid out its interim dividend of 32 cents per share in February, followed by its final dividend, worth 33 cents per share, in August. That total of 65 cents per share gives Transurban a trailing dividend yield of 4.48% at the current share price.

Transurban is one of the few ASX 200 passive income stocks to give its investors forward guidance when it comes to dividends.

Earlier this month, the toll road operator revealed that it intends to pay out 69 cents per share over 2026. That will come from an interim dividend worth 34 cents per share, and presumably, a final dividend of 35 cents per share.

Let’s say that does turn out to be accurate (the company did caveat the announcement with “subject to performance and economic factors”). Those payouts would give this passive income stock a forward dividend yield of 4.61% at today’s pricing.

Keep in mind that Transurban’s dividends usually don’t come with much in the way of franking credits. Even so, many passive income investors might find that yield difficult to turn down in today’s environment.

The post Down 8%, this passive income stock offers a 4.6% dividend yield! appeared first on The Motley Fool Australia.

More reading

• 3 ASX dividend shares to buy with $5,000
• Transurban announces 34c interim distribution and reaffirms FY26 guidance
• Are Transurban shares a buy for dividend income right now?
• 3 ASX dividend machines I think will keep paying for decades
• 3 ultra-reliable ASX dividend stocks I’d buy for long-term income

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Analysts at Macquaire are forecasting some serious upside for Wisetech Global Ltd (ASX: WTC) shares, saying the company “can and will fundamentally reshape the logistics industry”.

Wistech shares have bounced back recently after hitting a 12-month low of $61.49 in November. The stock is now changing hands for $74.49, but the team at Macquarie still believe the shares are materially undervalued following an investor day presentation this week.

Company taking big swings

Wisetech chief executive Zubin Appoo said in his presentation to investors that the company was focused on “our big rocks”, which were initiatives which moved the needle and drove value for the company.

Those big rocks, and everything we do, anchor back to why we exist. We build products that solve the most complex, high-stakes problems in global trade and logistics – and for our customers that translates into two things that matter above all else: efficiency and throughput at levels they couldn’t previously reach, and compliance and risk reduction in a world where global trade is only becoming more complex.

Mr Appoo said the company was also harnessing artificial intelligence to drive productivity across products and inside the company itself.

Shares looking cheap

The team at Macquarie have analysed the investor day presentations and as a result, have upgraded their rating on Wisetech shares to outperform.

They said the company was a true innovator in the logistics sector.

Wisetech can and will fundamentally reshape the logistics industry. We see their highly differentiated proprietary dataset as a competitive advantage that, coupled with E2Open, increases confidence in execution. However, with more than 90% of revenues from customers perceiving disruption, friction will remain very high. These challenges are commensurate with the size and deliverability of the opportunity, but (with) a changing growth dynamic … it will not be an easy path.

Macquarie said there were several risks to guidance for Wisetech, including the “inherent friction in reshaping a market”, which the company was doing with its container transport optimisation product, for example.

But they said they were “more confident in the long-term execution” while remaining cautious on the FY26 result and guidance for FY27.

Macquarie said new product delays, potential reinvestment and customer friction were the risks over the medium term, “however, execution risks are commensurate with the size and deliverability of a massive market opportunity”.

Macquarie has a 12 month price target of $108.50 on Wisetech shares, which coupled with the dividend, would reflect a total shareholder return of 49.8 per cent over a year if achieved.

Wisetech was valued at $24.8 billion at the close of trade on Thursday.

The post Macquarie tips 50% upside for Wisetech Global shares appeared first on The Motley Fool Australia.

More reading

• How on earth has the WiseTech Global share price exploded 20% in 17 days?
• Bell Potter names the best ASX 200 shares to buy in December
• 4 ASX shares I’d buy today with $10,000
• These ASX innovators could be the market’s next big winners
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has positions in WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two popular S&P/ASX 200 Index (ASX: XJO) media shares – REA Group Ltd (ASX: REA) and Nine Entertainment Co Holdings Ltd (ASX: NEC) – are hovering around year-to-date lows.

While the drivers are different, both ASX 200 media shares are facing a mix of structural headwinds, regulatory pressure, and investor re-rating.

Let’s take a closer look at both media companies and find out whether analysts consider the recent downturn a chance to buy at lower prices.

REA Group Ltd 

The share price of REA Group, the owner of realestate.com.au, has tumbled 20% in the past six months and 9.7% in the past month to $192.41 at the time of writing.

The decrease appears to be more about sentiment and future growth expectations than a collapse in fundamentals. On paper, the long-term business of this ASX 200 media share remains operationally strong. REA Group dominates its market, the pricing model is powerful, and earnings are still growing.

However, there are a few reasons why investors are selling their REA Group shares. The company recently reported a decline in new national listings, and in May, the ACCC launched a probe into REA’s pricing practices.

Competition for REA could also be fiercer after competitor Domain was acquired by CoStar Group Inc (NASDAQ: CSGP) in August. 

Analysts remain cautiously optimistic. Morgans recently cut its target price for the next 12 months to $247. This is a little higher than the average price target set by analysts and indicates a 28% upside from its current share price. 

Analysts at Macquarie Group Ltd (ASX: MQG) recently sliced their 12-month target to $220 because of uncertainty around AI, increased competition, and the ACCC regulatory investigation.

Macquarie’s target is on the low side, suggesting an upside of 14%.  

Nine Entertainment Co Holdings Ltd

Nine Entertainment’s share price drop was mainly technical, linked to a special dividend paid after selling its 60% stake in Domain in May. On the ex-dividend date (11 September), the ASX 200 media share fell sharply by 34% to reflect this payout.  

Beyond the special dividend, the media company is also battling a weaker business outlook. Analysts are particularly concerned about Nine’s reliance on its television business, which is vulnerable to a softer advertising market. That has been a reason for some brokers to cut revenue estimates for 2026 from $2.7 billion to $2.3 billion.

In the past 6 months, Nine Entertainment shares have lost 30.5% in value. At the time of writing, the media stock trades at $1.11 per share, almost 11% lower than a year ago.

The main challenge for Nine Entertainment will be to stabilise earnings with its core television and radio assets and deliver growth through digital platforms, such as Stan.

The research team at Macquarie said they remained cautious with regard to free-to-air television advertising spending, “and the need to constantly manage costs to support earnings”.

In recent weeks, most analysts have downgraded their price targets to an average of $1.44, suggesting a 28% upside at the current share price. The majority of analysts still rate the media stock a hold or buy, mainly due to the weaker share price.

The post Where to from here for these 2 ASX 200 media shares appeared first on The Motley Fool Australia.

More reading

• Top ASX shares to buy right now with $1,000
• Which three media companies could deliver double-digit returns?
• This is a great place to invest $1,000 into ASX shares right now
• Why today’s cheap ASX shares could double my money during the next bull market
• 5 ASX 200 large-cap shares re-rated by Morgans

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CoStar Group and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Nine Entertainment. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.